A Phase II Dose-Finding Study of weekly pemetrexed in combination with Radiotherapy in locally advanced pancreatic adenocarcinoma.
Phase of Trial: Phase II
Latest Information Update: 25 Feb 2012
At a glance
- Drugs Pemetrexed (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 25 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Jul 2011 New trial record